Skip to content
Riskpilot
← Back to search
Sign in
Get full access
OmicsDriven IVS
IVS
Dissolved
Advertising protection
CVR 39659131
Østergade 76, 4340
Tølløse
Forskning og eksperimentel udvikling indenfor bioteknologi
·
NACE 721100
Est. 2018 · 8 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Forskning og eksperimentel udvikling indenfor bioteknologi
/
OmicsDriven IVS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2019
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2019
Income statement
DKK thousands
Item
2019
Gross profit
—
Staff expenses
-0
EBITDA
-1
Depreciation & amort.
-0
EBIT
-1
Net financials
-1
Profit before tax
-2
Tax
-0
Net profit
-2
Balance sheet
DKK thousands
Item
2019
Total assets
9
Equity
8
Long-term debt
0
Short-term debt
0
Total debt
0
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-56100.0%
This company
2019
2019
Equity ratio
94.8%
This company
38.2%
Market median
+148% vs market
2019
2019
Return on equity
-21.4%
This company
18.4%
Market median
-216% vs market
2019
2019
Net profit margin (of gross profit)
-176400.0%
This company
2019
2019
Asset turnover (of gross profit)
0.00×
This company
2019
2019
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
2019
2019
Annual reports & filings
Annual report 2019
Filed via CVR / Virk · Period 2018-06-11 – 2019-05-31
View
PDF
More on OmicsDriven IVS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
